Role of adrenal venous sampling in primary aldosteronism: Salford royal NHS foundation trust experience

2017 ◽  
Vol 43 (12) ◽  
pp. 2396
Author(s):  
R. Acharya ◽  
T.M. Kearney ◽  
N. Chalmers ◽  
I.D. Anderson ◽  
H.E. Doran
2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Delin Ma ◽  
Xiaming Liu ◽  
Liwen Zeng ◽  
Penghui Yuan ◽  
Zheng Liu ◽  
...  

2006 ◽  
Vol 30 (4) ◽  
pp. 624-627 ◽  
Author(s):  
Antonio Toniato ◽  
Paolo Bernante ◽  
Gian Paolo Rossi ◽  
Maria Rosa Pelizzo

2019 ◽  
Vol 34 (1) ◽  
pp. 34-42 ◽  
Author(s):  
Yuichi Fujii ◽  
◽  
Yoshiyu Takeda ◽  
Isao Kurihara ◽  
Hiroshi Itoh ◽  
...  

2011 ◽  
pp. P2-604-P2-604
Author(s):  
Akiyo Tanabe ◽  
Mika Tsuiki ◽  
Aya Tsumagari ◽  
Hitomi Kimura ◽  
Mitsuhide Naruse ◽  
...  

2021 ◽  
Author(s):  
Filippo Crimì ◽  
Alessandro Spimpolo ◽  
Diego Cecchin ◽  
Gian Paolo Rossi

Soinio et al. recently compared the diagnostic accuracy of 11C-metomidate PET (11C-MTO-PET) and cosyntropin-stimulated adrenal venous sampling (AVS) for the subtyping of patients with primary aldosteronism (PA), who were diagnosed according to the 2008 Endocrine Society guidelines. They concluded that 11C-MTO-PET offered no diagnostic usefulness in subtyping of PA patients. In our view, this conclusion needs to be taken with great caution owing to a number of concerns that can be raised concerning their study


Sign in / Sign up

Export Citation Format

Share Document